Remove 2004 Remove Leads Remove Networking
article thumbnail

The EU HTA regulation: a new frontier for access to innovative technologies

European Pharmaceutical Review

1 The regulation is the culmination of a long debate between European Union (EU) Member States and health sector stakeholders, triggered by joint actions such as European Network for Health Technology Assessment (EUnetHTA) and formalised through the European Commission (EC)’s proposal in January 2018. effectiveness and therapeutic efficacy.

article thumbnail

Novel oral chemotherapeutic holds potential for stomach cancer patients

European Pharmaceutical Review

The drug is recognised in several international clinical guidelines for use as monotherapy or combination treatment regimens for advanced gastric cancer, including the European Society for Medical Oncology (ESMO), 2 the American Society of Clinical Oncology (ASCO) and the National Comprehensive Cancer Network (NCCN).

Patients 104
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Delivering Improved Disease Awareness Through More Strategic Partnerships

PM360

The campaign started when AstraZeneca approached LUNGevity to take the lead, but since then they have brought on more than 20 pharma partners that are supporting it both financially and helping push out the messaging. Founded in 2004 by Dr. Olajide Williams and hip hop icon Doug E.

Education 105
article thumbnail

Computed tomography for in-depth investigation of freeze-dried products

European Pharmaceutical Review

The honeycomb-like pore structure, which can be seen in elegant cakes, fades into an irregular network with rod-like structures, which are partially collapsed and have drop-shaped ends. Int J Pharm 2004; 271(1-2): 215–24 [[link] 15129988] 2. References 1. Sinka IC, Burch SF, Tweed JH, Cunningham JC. Hancock BC, Mullarney MP.

article thumbnail

Cancer: Progress but a long way to go

World of DTC Marketing

In recent years, early detection and treatment improvements have helped boost the 3-year survival rate for lung cancer from 21% in 2004 to 31% in 2015 through 2017. But it’s’ still the leading cause of cancer deaths. American Cancer Society’s ACS ). sustaining life)?

article thumbnail

What Is Sports Medicine Medical Sales With Jordan Rawlins

Evolve Your Success

The ones that are doing that stand out and lead at the top of the pack. I would sit down and have coffee with them once a week and go over their leads. They’re opening a new business,” we pass leads back and forth. It’s network. You build a network in this industry. It was a network that I trusted.

article thumbnail

Uri Goren

Cadensee

40:28 Are there any social networking tools that can be used to differentiate B2B from B2C. When he was going through his cancer, he died in 2004. And second of all, you should see who leads the anti-vaxxer; it's usually doctors. Are there any social networking tools that you can use to do that? Uri Goren: So, we do.